★ Immunology IBD Quiz
What were the treatment arms, and their duration, for the UNITI-1 and UNITI-2 induction studies?
A. Ustekinumab ~6 mg/kg or 130 mg, versus adalimumab over a 12-week period
B. Ustekinumab ~3 mg/kg or 220 mg versus vedolizumab over an 8-week period
C. Ustekinumab ~6 mg/kg or 130 mg, versus placebo over an 8-week period
D. Ustekinumab ~4 mg/kg versus adalimumab and placebo over a 12-week period
Select your answer:
Topics:
Bariatric Surgery and Diabetes Biology Assessment Differentiation and Division of Human Cells Food and Health & Bones and Muscles Human Anatomy Study Guide Nutrition and Calorific Value Excretory and Musculoskeletal System Infection Eye Cardiorespiratory System Inner Ear Neuroanatomy Biochemistry: Carbohydrates and Lipids Kinetics Medical Microbiology Biochemistry LabOther quiz:
Skills for Health › ViewCompare the structures of animals with each other and with humans.
A. Comparative Anatomy
B. Comparative Physiology
Nail Disorders and Diseases › View
A rare and serious type of skin cancer that begins in the nail matrix
A. Ridged nail
B. Pyogenic granuloma
C. Nail melanoma
D. Onychia